Medium Chain Triglyceride Compositions for Novel Applications

The present inventive concept discloses novel applications of medium chain triglyceride compositions, expanding their use beyond brain energy deficiency conditions and neurological diseases to athletic performance, unmanned aerial vehicles, cognitive function enhancement, and skin condition treatment.

The original patent disclosed the use of medium chain triglyceride compositions for treating brain energy deficiency conditions and neurological diseases. However, the present inventive concept addresses the limitation of these compositions being confined to a specific medical context, and instead, explores their potential in entirely new industries and fields.

The present inventive concept comprises a medium chain triglyceride composition comprising MCT-C8 and MCT-C10, which can be used in various novel applications. For instance, the composition can be used to optimize athletic performance by providing ketones to an athlete's body, reduce muscle cramping in athletes, or serve as a fuel source for unmanned aerial vehicles. Additionally, the composition can enhance cognitive function in individuals with attention deficit hyperactivity disorder or reduce inflammation in skin conditions. The ratio of MCT-C8 to MCT-C10 can vary depending on the specific application, ranging from 50:50 to 80:20 (mol/mol) for athletic performance to 30:70 to 70:30 (mol/mol) for cognitive function enhancement.

The present inventive concept introduces a new and non-obvious use of medium chain triglyceride compositions, departing from the original patent's medical focus and exploring their potential in diverse industries. The inventive step lies in recognizing the versatility of these compositions and adapting them to address specific challenges in athletic performance, unmanned aerial vehicles, cognitive function enhancement, and skin condition treatment.

Alternative embodiments of the present inventive concept could include varying the ratio of MCT-C8 to MCT-C10, using different types of medium chain triglycerides, or combining the composition with other nutrients or supplements. Additionally, the composition could be administered in different forms, such as capsules, powders, or energy bars, to cater to various user preferences.

The present inventive concept has significant commercial potential in various industries, including sports nutrition, unmanned aerial vehicles, pharmaceuticals, and cosmetics. The target market includes athletes, individuals with attention deficit hyperactivity disorder, and those suffering from skin conditions, as well as manufacturers of unmanned aerial vehicles and other industries that could benefit from the use of medium chain triglyceride compositions.